IL33 and cirrhosis of liver: This finding was in line with the available observation that the liver IL‐33 concentration was decreased in HBV‐ACLF patients with accompanying liver cirrhosis.39 Thus, we may speculate that by interfering with IL‐33, the increased sST2 levels further block bioactivity with respect to the function of IL‐33.